Literature DB >> 15919795

Beta-cell function across the spectrum of glucose tolerance in obese youth.

Ram Weiss1, Sonia Caprio, Maddalena Trombetta, Sara E Taksali, William V Tamborlane, Riccardo Bonadonna.   

Abstract

The profile of insulin secretion and the role of proinsulin processing across the spectrum of glucose tolerance in obese youth have not been studied. The aims of this study were to define the role of insulin secretion and proinsulin processing in glucose regulation in obese youth. We performed hyperglycemic clamps to assess insulin secretion, applying a model of glucose-stimulated insulin secretion to the glucose and C-peptide concentration data. Thirty obese youth with normal glucose tolerance (NGT), 22 with impaired glucose tolerance (IGT), and 10 with type 2 diabetes were studied. The three groups had comparable anthropometric measures and insulin sensitivity. The glucose sensitivity of first-phase secretion showed a significant stepwise decline from NGT to IGT and from IGT to type 2 diabetes. The glucose sensitivity of second-phase secretion was similar in NGT and IGT subjects yet was significantly lower in subjects with type 2 diabetes. Proinsulin-to-insulin ratios were comparable during first- and second-phase secretion between subjects with NGT and IGT and were significantly increased in type 2 diabetes. Obese youth with IGT have a significant defect in first-phase insulin secretion, while a defect in second-phase secretion and proinsulin processing is specific for type 2 diabetes in this age-group.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919795     DOI: 10.2337/diabetes.54.6.1735

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  62 in total

1.  Clinical trials in youth with type 2 diabetes.

Authors:  Julie Anne L Gemmill; Rebecca J Brown; Radha Nandagopal; Luisa M Rodriguez; Kristina I Rother
Journal:  Pediatr Diabetes       Date:  2011-02       Impact factor: 4.866

Review 2.  Insulin resistance in type 2 diabetic youth.

Authors:  Kara Mizokami-Stout; Melanie Cree-Green; Kristen J Nadeau
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-08       Impact factor: 3.243

3.  Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  R C Loopstra-Masters; S M Haffner; C Lorenzo; L E Wagenknecht; A J Hanley
Journal:  Diabetologia       Date:  2011-09-30       Impact factor: 10.122

Review 4.  Type 2 diabetes and the metabolic syndrome in children and adolescents.

Authors:  José F Cara; Rochelle L Chaiken
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 5.  Development of type 2 diabetes in children and adolescents.

Authors:  Ram Weiss; Sara E Taksali; Sonia Caprio
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 6.  Type 2 diabetes mellitus in pediatrics: a new challenge.

Authors:  Michelle Van Name; Nicola Santoro
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

7.  The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes.

Authors:  Yen-Lin Chen; Jiunn-Diann Lin; Te-Lin Hsia; Frank Chiahung Mao; Chun-Hsien Hsu; Dee Pei
Journal:  Eur J Nutr       Date:  2013-03-14       Impact factor: 5.614

8.  Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes.

Authors:  Deborah A Elder; Jessica G Woo; David A D'Alessio
Journal:  Pediatr Diabetes       Date:  2010-08       Impact factor: 4.866

Review 9.  Current treatment options for type 2 diabetes mellitus in youth: today's realities and lessons from the TODAY study.

Authors:  Minu M George; Kenneth C Copeland
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

10.  β-Cell lipotoxicity after an overnight intravenous lipid challenge and free fatty acid elevation in African American versus American white overweight/obese adolescents.

Authors:  Kara S Hughan; Riccardo C Bonadonna; SoJung Lee; Sara F Michaliszyn; Silva A Arslanian
Journal:  J Clin Endocrinol Metab       Date:  2013-03-22       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.